Skip to main content
Tianjin Ringpu Bio-Technology Co.,Ltd. logo

Tianjin Ringpu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 300119 ISIN · CNE100000TV1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,284 across all filing types
Latest filing 2025-11-28 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300119

About Tianjin Ringpu Bio-Technology Co.,Ltd.

https://www.ringpu.com

Tianjin Ringpu Bio-Technology Co.,Ltd. is a high-tech enterprise specializing in the research, development, production, and sale of animal health products. The company offers a comprehensive portfolio that includes veterinary biological products, chemical drugs, feed additives, and pet health solutions. Its product range covers vaccines for poultry and livestock, as well as various pharmaceutical formulations such as injections, powders, and oral solutions. Ringpu Bio-Technology emphasizes innovation through its dedicated R&D centers, focusing on disease prevention and treatment to support the global animal husbandry industry. The company provides integrated health management services and high-quality veterinary medicines to ensure food safety and animal welfare.

Recent filings

Filing Released Lang Actions
防范控股股东及关联方占用公司资金管理制度（2025年11月）
Governance Information Classification · 95% confidence The document is a detailed internal policy titled '防范控股股东及关联方占用公司资金管理制度' (Management System for Preventing Controlling Shareholders and Related Parties from Occupying Company Funds) issued by 瑞普生物股份有限公司. It outlines principles, responsibilities, and procedures to prevent misuse of company funds by controlling shareholders and related parties. The content is regulatory and governance-related, focusing on internal control and compliance with laws and stock exchange rules. It does not contain financial statements, audit opinions, earnings data, or meeting materials. It is not an announcement or a brief notice but a substantive governance document. Therefore, it fits best under Governance Information (CGR). The document length is 3590 characters, which is relatively short but contains the full policy text, not just an announcement or summary, so it is not RPA or RNS. Hence, the classification is CGR with high confidence.
2025-11-28 Chinese
内幕信息知情人登记备案制度（2025年11月）
Governance Information Classification · 95% confidence The document is a detailed internal policy document titled '内幕信息知情人登记备案制度' (Insider Information Insider Registration and Filing System) issued by 瑞普生物股份有限公司. It outlines the company's procedures and rules for managing insider information, including definitions, scope, responsibilities, confidentiality, and penalties related to insider information. The document references relevant laws and regulatory requirements but does not contain financial statements, earnings data, or shareholder meeting materials. It is a governance-related document focusing on internal controls and compliance regarding insider information. Therefore, it fits best under Governance Information (CGR). The document length (7244 characters) and content confirm it is a full policy document, not a brief announcement or certification.
2025-11-28 Chinese
突发事件处理制度（2025年11月）
Governance Information Classification · 95% confidence The document is titled '突发事件处理制度' which translates to 'Emergency Incident Handling System' or 'Sudden Event Handling System' for 瑞普生物股份有限公司 (Rip Bio Co., Ltd.). It outlines the company's internal policies and procedures for handling sudden or emergency events that could impact the company’s operations, governance, financial status, reputation, or stock price. The content includes definitions, scope, principles, organizational structure, prevention mechanisms, handling procedures, evaluation, and disciplinary measures related to emergency events. There is no financial data, no report of financial results, no audit information, no voting results, no management changes, no earnings release, no capital update, no legal proceeding update, no merger or acquisition information, no dividend notice, no proxy solicitation, no regulatory filing, no certification, and no announcement of report publication. Instead, it is a governance or internal control document detailing company policies and procedures. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 5797 characters, which is sufficient for a detailed policy document, not a brief announcement or notice.
2025-11-28 Chinese
信息披露事务管理制度（2025年11月）
Governance Information Classification · 95% confidence The document is a detailed internal management system for information disclosure of a company, including references to laws, regulations, and specific disclosure requirements for various types of reports such as annual reports, interim reports, quarterly reports, and temporary reports. It outlines procedures, responsibilities, and standards for information disclosure, including the roles of the board, management, and disclosure departments. The content is about governance and compliance related to information disclosure rather than the disclosure of financial results or specific events. It does not contain actual financial data or results but rather the rules and procedures governing disclosures. Therefore, this document fits best under Governance Information (CGR), as it details the company's internal rules and governance practices related to information disclosure.
2025-11-28 Chinese
信息披露暂缓与豁免业务管理制度（2025年11月）
Governance Information Classification · 95% confidence The document is a detailed internal policy and procedural manual regarding the company's management of information disclosure delays and exemptions. It references regulatory frameworks such as the Shenzhen Stock Exchange rules and Chinese securities laws, and outlines internal approval processes, confidentiality commitments, and record-keeping related to information disclosure. There are no financial statements, earnings data, or report summaries present. The document is not an announcement of a report, nor is it a transcript, presentation, or voting result. It is a governance-related document detailing internal rules and procedures for compliance with disclosure regulations. Therefore, the most appropriate classification is Governance Information (CGR). The document length (3772 characters) and content support this classification with high confidence.
2025-11-28 Chinese
关于取得新兽药注册证书的公告
Regulatory Filings Classification · 95% confidence The document is a company announcement regarding the acquisition of a new veterinary drug registration certificate issued by the Ministry of Agriculture and Rural Affairs. It details the product, its development, and regulatory compliance. The document is short (1238 characters) and serves as a formal public notice of a regulatory approval event. It does not contain financial data, management discussion, or detailed report content. It is not an annual or interim report, earnings release, or any financial filing. It is a regulatory announcement about a product approval, fitting best under Regulatory Filings (RNS).
2025-11-27 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.